The histologic spectrum of soft tissue spindle cell tumors with NTRK3 gene rearrangements.
Adolescent
Adult
Aged
Biomarkers, Tumor
/ genetics
Child
Child, Preschool
Female
Gene Fusion
/ genetics
Gene Rearrangement
/ genetics
Humans
Immunohistochemistry
In Situ Hybridization, Fluorescence
/ methods
Infant
Male
Middle Aged
Receptor, trkC
/ genetics
Sarcoma
/ genetics
Soft Tissue Neoplasms
/ genetics
Exome Sequencing
NTRK3
fibrosarcoma
fusion
malignant peripheral nerve sheath tumor
sarcoma
Journal
Genes, chromosomes & cancer
ISSN: 1098-2264
Titre abrégé: Genes Chromosomes Cancer
Pays: United States
ID NLM: 9007329
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
received:
16
04
2019
revised:
18
05
2019
accepted:
20
05
2019
pubmed:
22
5
2019
medline:
15
2
2020
entrez:
22
5
2019
Statut:
ppublish
Résumé
NTRK3-rearranged tumors other than infantile fibrosarcomas (IFSs) harboring the canonical ETV6-NTRK3 fusions are uncommon, and include mainly inflammatory myofibroblastic tumors and gastrointestinal stromal tumors. Herein, we describe an additional subset of seven tumors sharing NTRK3 gene rearrangements. The cohort included five females and two males (age range 1-67 years). Tumors were located in extremities, trunk, retroperitoneum, or intra-abdominal. In all tumors, fluorescence in situ hybridization (FISH) revealed rearrangements in NTRK3 accompanied by NTRK3 amplification in two cases. In three cases, RNA sequencing identified a fusion transcript composed of NTRK3 exon 14 fused to ETV6, TFG, and TPM4, respectively, retaining the NTRK3 kinase domain. All tumors were positive for pan-TRK by immunohistochemistry (IHC). Two cases showed low- to intermediate-grade histology composed of monomorphic spindle cells arranged in a patternless architecture, stromal bands, and perivascular rings of hyalinized collagen and coexpression of S100 and CD34. The remaining five cases were high-grade fascicular monomorphic spindle cell sarcomas, morphologically somewhat reminiscent of either malignant peripheral nerve sheath tumors (MPNSTs) or fibrosarcomas (FSs). Two high-grade NTRK3 sarcomas showed aggressive clinical behavior with development of lung metastases. Identification of high-grade NTRK3-rearranged sarcomas is clinically important, since the development of selective NTRK inhibitors has opened new avenues for targeted therapy. Although IHC for pan-TRK can be applied as a screening tool, molecular studies are recommended for a conclusive diagnosis of NTRK-rearranged neoplasms.
Identifiants
pubmed: 31112350
doi: 10.1002/gcc.22767
pmc: PMC6733642
mid: NIHMS1040149
doi:
Substances chimiques
Biomarkers, Tumor
0
Receptor, trkC
EC 2.7.10.1
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
739-746Subventions
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA140146
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA217694
Pays : United States
Informations de copyright
© 2019 Wiley Periodicals, Inc.
Références
Pediatr Blood Cancer. 2017 Aug;64(8):
pubmed: 28097808
Mod Pathol. 2016 Jan;29(1):4-13
pubmed: 26585554
Appl Immunohistochem Mol Morphol. 2008 May;16(3):246-50
pubmed: 18301245
Histopathology. 2016 Jul;69(1):72-83
pubmed: 26647767
Pediatr Dev Pathol. 2018 Jan-Feb;21(1):68-78
pubmed: 28683589
Cancer. 2018 Nov 1;124(21):4241-4247
pubmed: 30204247
Mod Pathol. 2014 Mar;27(3):390-5
pubmed: 24030747
Genes Chromosomes Cancer. 2018 Dec;57(12):611-621
pubmed: 30276917
N Engl J Med. 2018 Feb 22;378(8):731-739
pubmed: 29466156
Am J Surg Pathol. 2016 Oct;40(10):1407-16
pubmed: 27259011
J Cutan Pathol. 2018 Dec;45(12):933-939
pubmed: 30175468
J Thorac Oncol. 2019 May;14(5):825-834
pubmed: 30550870
J Pathol. 2016 Apr;238(5):700-10
pubmed: 26863915
J Pathol. 2016 Mar;238(4):543-9
pubmed: 26606880
Am J Surg Pathol. 2016 Apr;40(4):479-89
pubmed: 26645727
Nat Genet. 2013 Feb;45(2):180-5
pubmed: 23313952
J Transl Med. 2016 Dec 14;14(1):339
pubmed: 27974047
Nat Med. 2014 Dec;20(12):1479-84
pubmed: 25384085
Am J Surg Pathol. 2018 Jun;42(6):791-798
pubmed: 29553955
Am J Surg Pathol. 2019 Apr;43(4):435-445
pubmed: 30585824
Am J Surg Pathol. 2019 Apr;43(4):523-530
pubmed: 30520818
Mod Pathol. 2019 Jul;32(7):1008-1022
pubmed: 30877273
J Mol Diagn. 2015 May;17(3):251-64
pubmed: 25801821
Histopathology. 2018 Oct;73(4):634-644
pubmed: 29863809